Image: Curtin School of Population Health’s Associate Professor Anthony Kicic. Supplied.
Common bacterial infections such as golden staph (staphylococcus) and pseudomonas can quickly put a person’s life at risk and are typically treated with medicines such as antibiotics.
However, many of the germs responsible for these infections can grow resistant to the medicines used to treat them, eventually leaving physicians with no other management options but to use higher concentrations and different combinations — which can cause serious side-effects for patients.
It’s known as antimicrobial resistance (AMR) — and Curtin University School of Population Health’s Associate Professor Anthony Kicic is investigating a natural alternative to battle it.
Associate Professor Kicic is researching natural viral predators of bacteria known as bacteriophages (or more commonly, phages), which can be used therapeutically.
“AMR is expected to kill more than 10 million people annually by 2050, but bacteriophage viruses are like superhero bugs found everywhere in nature,” Associate Professor Kicic said.
“They’re like something out of a movie: rather than make us sick, they seek out particular bugs, go inside them to create baby viruses, which then all burst out and kill the bacteria.
“Once all of the bacteria are killed, the phage has no host, so it too dies out.”
Phages are also a strong alternative for patients with allergies to medications, such as penicillin. However, identifying the correct phage to combat a particular bacterial infection is a time-consuming laboratory process — and time is often in short supply when medical staff are treating a critically ill patient.
Associate Professor Kicic is partnering with the Wal-yan Respiratory Research Centre at the Telethon Kids Institute to investigate how artificial intelligence (AI) can speed up this process to save lives, with the Western Australian Government recently awarding the project an Innovation Challenge 2023 – Generative Artificial Intelligence Applications (GAIA) grant.
Associate Professor Kicic is working on an AI platform known as PHAEDRA (PHage bacteriA genomE Diagnostics Recognition via Artificial Intelligence) which will run computer simulations to quickly determine which of the thousands of phages available will be most suitable to use on a case-by-case basis.
“Australians with resistant infections are already being treated with phages, but the weakest link in the chain of service is the four to five days needed to identify the most effective phages for a specific individual’s given infection,” he said.